GIIB HEALTHCARE PRODUCTS Sdn Bhd
About GIIB HEALTHCARE PRODUCTS Sdn Bhd
GIIB HEALTHCARE PRODUCTS Sdn Bhd appears in 3 reported Malaysia court cases (2025). GIIB HEALTHCARE PRODUCTS Sdn Bhd is recorded as Respondent (2) and Applicant (1). These cases were heard before MYHC (3).
On the court record
Pairs the CIPAA 2012 set-aside-and-enforcement contest with the discretionary timetable for opposing a winding-up petition under the Companies (Winding-up) Rules 1972.
GIIB Healthcare Products Sdn Bhd appears in the reported judgments as a manufacturing company involved in construction-adjudication and insolvency-adjacent disputes in the High Court (Mahkamah Tinggi). Its matters pair the enforcement and setting-aside of an adjudication decision with the procedural mechanics of a winding-up petition.
In connected proceedings the company and a counterparty each engaged the Construction Industry Payment and Adjudication Act 2012 from opposing directions. One application was brought under sections 15(b) and (d) of the Act to set aside an adjudication decision; the mirror proceeding sought to sustain it. The court's task was to determine whether the statutory grounds for setting aside — such as a denial of natural justice or the adjudicator acting in excess of jurisdiction — were made out, and the decisions record the application being allowed or dismissed on those grounds.
A distinct matter placed the company on the insolvency plane. There the issue was leave to file an affidavit in opposition to a winding-up petition out of time under rule 193 of the Companies (Winding-up) Rules 1972, where the delay of nearly ten months was said to be inordinate and inexcusable and to reflect a calculated strategy to obstruct the petition's progress; against that, the delay was explained by financial constraints, misappropriation of funds and ongoing disputes among directors. The court considered that rules 193 and 194 are wide and not curtailed by rigid timelines, that time may be enlarged even after a hearing date is fixed, and that the conduct of the applicant, the length of and reasons for the delay, and the overall interests of justice must be weighed. The decisions show a manufacturer contesting both statutory adjudication and the timetable of its own winding-up. The two strands are connected in practice, because an adverse adjudication decision or an unmet judgment debt is often what precipitates a winding-up petition against a company in the construction and manufacturing sector, and the company's ability to be heard in opposition then depends on the court's willingness to enlarge time under the winding-up rules. The reported reasoning is therefore instructive on the discretion the court exercises when a company seeks a further opportunity to resist its own liquidation, and on the weight given to explanations of delay that rest on financial difficulty and internal disputes among directors rather than on any fault of the court process.
How many Malaysia court cases involve GIIB HEALTHCARE PRODUCTS Sdn Bhd?
GIIB HEALTHCARE PRODUCTS Sdn Bhd appears in 3 reported Malaysia court cases (2025).
Which courts does GIIB HEALTHCARE PRODUCTS Sdn Bhd appear in?
GIIB HEALTHCARE PRODUCTS Sdn Bhd appears before MYHC (3).
How did GIIB Healthcare Products Sdn Bhd engage the CIPAA 2012?
Through connected applications to set aside an adjudication decision under sections 15(b) and (d) of the Construction Industry Payment and Adjudication Act 2012 and to sustain it, with the court deciding whether statutory grounds such as breach of natural justice or excess of jurisdiction were established.
What did the court consider on the late affidavit in the winding-up petition?
Whether leave should be granted to file an affidavit in opposition out of time under rule 193 of the Companies (Winding-up) Rules 1972 despite a delay of nearly ten months, holding that the rules are wide and not curtailed by rigid timelines and that the applicant's conduct, the reasons for delay and the interests of justice must be weighed.